Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE− / − Mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE− / − Mice

Published:2009-01 Issue:1 Volume:53 Page:60-65
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Fraser Heather,Hislop Colin,Christie Robert M,Rick Heather L,Reidy Charles A,Chouinard Michael L,Eacho Patrick I,Gould Kenneth E,Trias Joaquim

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference36 articles.

1. Secretory phospholipase A2.;Murakami;Biol Pharm Bull,2004

2. The phospholipase A2 superfamily and its group numbering system.;Schaloske;Biochim Biophys Acta,2006

3. Expression of secretory phospholipase A2s in human atherosclerosis development.;Kimura-Matsumoto;Atherosclerosis,2008

4. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.;Antonio;Biochem J,2002

5. Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundant.;de Beer;Arterioscler Thromb Vasc Biol,2006

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions of small molecule inhibitors with secreted phospholipase A₂: A review of the structural data;Chemical Biology & Drug Design;2024-01-29

2. Phospholipase A2 inhibitors in lung cancer therapy;Phospholipases in Physiology and Pathology;2023

3. Identification of potential inhibitor(s) against phospholipase A2 using a network pharmacology-based approach;Phospholipases in Physiology and Pathology;2023

4. Exploring the Effect and Mechanism of Si-Miao-Yong-An Decoction on Abdominal Aortic Aneurysm Based on Mice Experiment and Bioinformatics Analysis;Evidence-Based Complementary and Alternative Medicine;2022-05-31

5. Hyperinflammation, apoptosis, and organ damage;Experimental Biology and Medicine;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3